Trial intelligence / Profile preview

Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Facial and Intertriginous Psoriasis

2007-005501-22Phase 2Completed

Sponsor
LEO Pharma
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of calcipotriol + hydrocortisone in plaque psoriasis, sponsored by LEO Pharma. Primary endpoints: Adrenal response to ACTH challenge at Week 4 and Adrenal response to ACTH challenge at Week 8. Started Jan 2008; status: completed.

02

Drugs

calcipotriol + hydrocortisone
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on 2007-005501-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005501-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call